In VivoSpeak to champions of the Austrian life sciences sector and one hears a resounding message: the country is busy with advanced research and strong talent. “I shouldn't say this, but I feel like we have
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Roche Exits Gene Therapy Delivery Pact